Sens. Durbin and Braun's bipartisan "Protecting Patients from Deceptive Drug Ads Online Act" aims to impose penalties for misleading prescription drug claims made online, particularly by influencers.
The bill specifically targets those making false claims for financial gain, emphasizing reports on payments from drug manufacturers to healthcare providers and influencers to ensure transparency.
Research indicates that patients exposed to direct-to-consumer drug ads are more likely to request prescriptions, which can lead to inappropriate medication requests and consumption.
In response to stalled FDA guidance, the legislation seeks to enhance accountability in telehealth and social media advertising to protect patients from undue influence.
Collection
[
|
...
]